BLACK LABEL

Serial Number 87353379
606

Registration Progress

Application Filed
Feb 28, 2017
Under Examination
Mar 27, 2018
Approved for Publication
Jan 30, 2018
Published for Opposition
Jan 30, 2018
Registered

Trademark Image

BLACK LABEL

Basic Information

Serial Number
87353379
Filing Date
February 28, 2017
Published for Opposition
January 30, 2018
Abandonment Date
November 2, 2020
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 2, 2020
Classes
005

Rights Holder

Tweed Inc.

03
Address
1 Hershey Drive
Smiths Falls, Ontario K7A0A8
CA

Ownership History

Tweed Inc.

Original Applicant
03
Smiths Falls, Ontario CA

Tweed Inc.

Owner at Publication
03
Smiths Falls, Ontario CA

Legal Representation

Attorney
Mark Mutterperl

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

36 events
Date Code Type Description Documents
Nov 2, 2020 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 2, 2020 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Mar 3, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 1, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 1, 2020 EXT4 S SOU EXTENSION 4 FILED Loading...
Mar 1, 2020 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 19, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 17, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 17, 2019 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 17, 2019 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 20, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 18, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 18, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 18, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 26, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 24, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 24, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 24, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 27, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 23, 2018 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 30, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 30, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 10, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 22, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 15, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 15, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 12, 2017 ALIE A ASSIGNED TO LIE Loading...
Dec 11, 2017 ALIE A ASSIGNED TO LIE Loading...
Dec 3, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 6, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 6, 2017 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 6, 2017 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 23, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
May 23, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 7, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 3, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
analgesic preparations; antibiotic preparations; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of acne; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical preparations for the treatment of glaucoma; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of metabolic disorders, namely, diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; pharmaceutical preparations for the treatment of skin irritations, namely, bee stings, sunburn, rashes, sores, corns, calluses, and acne; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for wounds; topical anesthetics; delivery systems in the nature of topical applications, namely, foams, gels, creams, sprays, lotions and ointments which act as a base and prepare the skin to receive therapeutic preparations that are absorbed into the blood stream through the skin
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005